OpenAlex
PricingAboutJobs
Log inGet started
Author

W. Wang

Institutions: Tianjin Medical University Cancer Institute and Hospital, University of California San Diego, Moores Cancer Center
Observed institutions: Tianjin Medical University Cancer Institute and Hospital, University of California San Diego, Moores Cancer Center
ORCID: 0009-0005-7979-1021
Observed ORCID: 0009-0005-7979-1021
OpenAlex ID: A5079340511
1494P Pooled efficacy and safety outcomes with tremelimumab plus durvalumab in participants (pts) with unresectable hepatocellular carcinoma (uHCC) from the combined China extension and global cohorts in the phase III HIMALAYA study
2025 · B. Sangro, S. Qin, et al. · Annals of Oncology · 6
WITHDRAWN: 679P Clinical outcomes of newly diagnosed PCNSL treated with rituximab-methotrexate-cytarabine with or without ibrutinib: A retrospective study
2025 · W. Wang, B. Wang, et al. · Annals of Oncology
1303 Preoperative chemoradiation with capecitabine for rectal cancer in elderly patients: A phase I trial
2015 · W. Liu, Y. Tang, et al. · European Journal of Cancer
Works count: 3
Citation count: 6
H-index: 1
I10-index:
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security